Beta-blockers in new onset CHD reduce cardiac risk only post-MI

July 22, 2014
Beta-blockers in new onset CHD reduce cardiac risk only post-MI

(HealthDay)—Use of beta-blockers among patients with new-onset coronary heart disease (CHD) appears to lower risk of cardiac events only among patients with a recent myocardial infarction (MI), according to a study published in the July 22 issue of the Journal of the American College of Cardiology.

Charlotte Andersson, M.D., Ph.D., from Gentofte University Hospital in Hellerup, Denmark, and colleagues studied outcomes in 26,793 consecutive patients discharged after the first CHD event ( or coronary revascularization) between 2000 and 2008 in an system. Included patients did not use beta-blockers in the year before entry.

The researchers found that 19,843 of the patients initiated beta-blocker treatment within seven days of discharge from their initial CHD event. There were 6,968 patients who had an MI or died over an average of 3.7 years of follow-up. There was an adjusted hazard ratio (HR) for mortality of 0.90 with the use of beta-blockers (95 percent confidence limits, 0.84 to 0.96), and an adjusted HR for death or MI of 0.92 (95 percent confidence limits, 0.87 to 0.97). There was a significant difference in the association between beta-blockers and outcomes between patients with and without a recent MI (HR for death: 0.85 versus 1.02; P = 0.007; and HR for death or MI: 0.87 versus 1.03; P = 0.005).

"Use of beta-blockers among patients with new-onset CHD was associated with a lower risk of only among with a recent MI," the authors write.

Explore further: Beta-blockers before surgery appear associated with lower risk of heart-related events

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Beta-blockers before surgery appear associated with lower risk of heart-related events

November 18, 2013
Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) 30 days after surgery in patients ...

Beta-blocker therapy cuts all-cause mortality in STEMI

June 18, 2014
(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with reduced all-cause mortality, ...

Beta-blockers have no impact on cocaine-related chest pain

June 3, 2014
(HealthDay)—For patients with cocaine-associated chest pain, there are no differences in outcome for those treated with or without β-blockers, according to a study published in the June 1 issue of The American Journal ...

Beta-blockers before coronary artery bypass grafting surgery not associated with better outcomes

June 16, 2014
Use of beta (β)-blockers in patients who have not had a recent heart attack but were undergoing nonemergency coronary artery bypass grafting (CABG) surgery was not associated with better outcomes.

Beta-blocker use not associated with lower risk of cardiovascular events

October 2, 2012
Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular ...

Beta-blockers may increase adverse cardiac events, patients at risk during noncardiac surgical procedure

October 28, 2013
A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.